Who Brands - Brand Ownership DirectoryWho Brands
HomeBrowse BrandsCategoriesCompaniesCompareBlogQuizAbout
HomeBrowse BrandsCategoriesCompaniesCompareBlogQuizAbout
Who Brands

Your trusted reference for brand ownership information. We provide factual, comprehensive data about who owns the brands you know.

Stay in the know

Get the latest ownership updates delivered to your inbox.

Browse

  • All Brands
  • Categories
  • Companies
  • Countries
  • Compare Brands
  • Blog
  • Brand Quiz
  • RSS Feed

Company

  • About Us
  • Methodology
  • Contact
  • FAQ
  • Submit a Brand
  • List Your Brand
  • Write for Us

Legal

  • Terms of Service
  • Privacy Policy
  • Cookie Policy
  • Affiliate Disclosure
  • Disclaimer

Support Us

☕Buy me a coffee

2026 Who Brands. All information is provided for educational purposes. Brand names and logos are trademarks of their respective owners.

  1. Home
  2. Brands
  3. Healthcare & Pharmaceuticals
  4. Optum Rx
Healthcare & Pharmaceuticals

Who Owns Optum Rx?

OptumRx is owned by UnitedHealth Group, Inc. (NYSE: UNH), a publicly traded American healthcare company headquartered in Minnetonka, Minnesota. OptumRx is the pharmacy benefits management segment of Optum, UnitedHealth Group's healthcare services platform. OptumRx processed 1.66 billion adjusted scripts in fiscal year 2025 and generated $154.7 billion in revenues, a 16% increase over 2024. It is one of the three largest pharmacy benefits managers in the United States alongside CVS Caremark and Express Scripts. UnitedHealth Group is led by CEO Stephen Hemsley, who returned to the role in May 2025.

Parent Company

UnitedHealth Group

Founded

2011

Status

Publicly Traded

Headquarters

Minnetonka, Minnesota, USA

Optum Rx Timeline

1977
UnitedHealth Group

Parent company established in Minnetonka, Minnesota, USA

Company Founded
2011

Optum Rx

Founded by UnitedHealth Group (consolidated under Optum brand in 2011; expanded via Catamaran acquisition 2015)

Founded
premiumpremiumUnited Statesall-agessocially responsibleOfficial Website

Who Owns Optum Rx?

  • Parent Company: UnitedHealth Group
  • Ownership Type: Wholly owned
  • Company Type: Publicly Traded
  • Stock Ticker: NYSE: UNH
BrandParent CompanyOwnership Type
Optum RxUnitedHealth GroupWholly owned

History of Optum Rx

  • Founded: 2011
  • Founders: UnitedHealth Group (consolidated under Optum brand in 2011; expanded via Catamaran acquisition 2015)

OptumRx's history begins with UnitedHealth Group's earlier pharmacy services operations, which were consolidated under the OptumRx name when the Optum brand was launched in 2011. UnitedHealth Group had been building pharmacy benefits management capabilities for many years before the OptumRx brand was created.

UnitedHealth Group's pharmacy benefits management operations in the early 2000s were relatively modest compared to the dominant players in the market, CVS Caremark and Medco Health Solutions (later acquired by Express Scripts). The company recognized that pharmacy benefits management was a strategically important capability for a large health insurer, as pharmacy costs represent a significant and growing portion of total healthcare spending.

The Optum brand was formally created in 2011 when UnitedHealth Group consolidated its existing pharmacy and care delivery services under a single unified platform. The pharmacy benefits management business was renamed OptumRx as part of this consolidation.

The most significant event in OptumRx's history was the 2015 acquisition of Catamaran Corporation, a pharmacy benefits management company, for approximately $12.8 billion. Catamaran had been formed through the merger of SXC Health Solutions and Catalyst Health Solutions in 2012 and had grown rapidly to become one of the larger pharmacy benefits managers in the United States. The Catamaran acquisition dramatically expanded OptumRx's scale, making it one of the three largest pharmacy benefits managers in the United States alongside CVS Caremark and Express Scripts.

The Catamaran acquisition brought OptumRx a large book of commercial pharmacy benefits management clients, sophisticated pharmacy technology platforms, and significant mail-order and specialty pharmacy capabilities. The integration of Catamaran's operations into OptumRx was a major undertaking that took several years to complete.

Following the Catamaran acquisition, OptumRx continued to grow both organically and through smaller acquisitions. The business expanded its specialty pharmacy capabilities, which manage high-cost medications for complex conditions such as cancer, autoimmune diseases, and rare diseases. Specialty pharmacy is a high-growth segment of the pharmacy market, as specialty medications represent a growing share of total drug spending.

In 2025, UnitedHealth Group announced that OptumRx would commit to passing through 100% of drug rebates received from pharmaceutical manufacturers to plan sponsors. This policy change represented a significant shift in OptumRx's business model, as pharmacy benefits managers have historically retained a portion of drug rebates as a source of revenue. The announcement reflected increasing regulatory and political pressure on pharmacy benefits managers' rebate practices.

OptumRx's full year 2025 revenues of $154.7 billion represented a 16% increase over 2024, driven by growth in pharmacy services and volume growth from new and existing clients. Earnings from operations were $7.2 billion, compared to $5.8 billion in 2024. Adjusted earnings from operations were $6.1 billion, compared to $5.8 billion a year ago. Adjusted scripts grew to 1.66 billion, up from 1.62 billion in 2024. The increase in earnings was primarily due to growth in both script volume and pharmacy services, as well as operating efficiencies.

In May 2025, CEO Andrew Witty stepped down and Stephen Hemsley returned as CEO. The 2026 outlook projects OptumRx revenues exceeding $150.5 billion, reflecting a planned reduction from 2025 due to membership attrition in UnitedHealthcare. Operating earnings are projected at greater than $6,250 million with an operating margin of approximately 4.2%.

About UnitedHealth Group

UnitedHealth Group operates through two primary platforms that work together to deliver comprehensive healthcare solutions: UnitedHealthcare and Optum. This integrated business model enables the company to serve the entire healthcare continuum, from insurance coverage to direct healthcare delivery and technology services, creating synergies that enhance both quality and efficiency.

UnitedHealthcare represents the company's health insurance and benefits division, providing coverage to individuals, employers, and government-sponsored programs including Medicare and Medicaid. In 2025, UnitedHealthcare served 49.8 million consumers and achieved revenues of $344.9 billion, representing 16% growth year-over-year. The division operates through multiple business segments including individual and family plans, employer-sponsored coverage, Medicare Advantage plans, and Medicaid managed care programs.

UnitedHealthcare's success stems from its extensive provider networks, innovative benefit designs, and focus on value-based care models. The company has developed sophisticated approaches to care coordination, preventive health programs, and chronic disease management that improve health outcomes while managing costs effectively. UnitedHealthcare's market leadership position enables it to negotiate favorable terms with healthcare providers and develop innovative insurance products that meet evolving consumer needs.

Optum delivers comprehensive healthcare services and technology solutions through three main segments that support the entire healthcare ecosystem:

Optum Health provides direct patient care and health services, operating clinics, surgical centers, and home health services. The segment employs healthcare professionals including physicians, nurses, and care coordinators who deliver integrated care to patients across various settings. Optum Health focuses on value-based care models that align financial incentives with health outcomes, creating more efficient and effective healthcare delivery systems.

Optum Insight offers data analytics, consulting, and technology services to healthcare organizations, payers, and life sciences companies. The segment leverages UnitedHealth Group's vast healthcare data assets to provide insights that improve clinical outcomes, reduce costs, and enhance operational efficiency. Optum Insight's services include population health management, revenue cycle optimization, and healthcare technology implementation.

Optum Rx manages pharmacy benefits for millions of people, negotiating with pharmaceutical manufacturers and managing prescription drug programs. In 2025, Optum Rx achieved 15% revenue growth, demonstrating strong performance in the pharmacy benefits management market. The segment combines purchasing power with clinical expertise to optimize medication therapy, improve adherence, and manage drug costs effectively.

UnitedHealth Group's integrated business model creates significant competitive advantages. The company's ability to combine insurance coverage with direct healthcare delivery enables better care coordination, improved health outcomes, and more efficient resource utilization. This integration also provides valuable data insights that inform product development, care management programs, and operational improvements.

In 2025, UnitedHealth Group demonstrated exceptional financial performance with consolidated revenues of $447.6 billion, representing 12% growth year-over-year. The company's adjusted earnings from operations reached $21.7 billion, reflecting strong operational execution despite challenges including cyberattack-related costs and business restructuring charges.

The company's financial metrics demonstrate operational efficiency and strong cash generation. UnitedHealth Group achieved cash flows from operations of $19.7 billion in 2025, representing 1.5 times net income. The company maintains a debt-to-capital ratio of 43.9% and targets a long-term ratio of 40.0%, reflecting prudent financial management.

UnitedHealth Group employs approximately 440,000 people worldwide, making it one of the largest employers in the healthcare industry. The company's workforce includes healthcare professionals, technology specialists, data analysts, and business professionals who support the company's integrated healthcare delivery model.

Looking toward 2026, UnitedHealth Group has established revenue guidance greater than $439.0 billion and adjusted earnings outlook greater than $17.75 per share. The company expects to continue its growth trajectory while addressing ongoing challenges including medical cost trends, regulatory changes, and competitive pressures in the healthcare market.

  • Founded: 1977
  • Headquarters: Minnetonka, Minnesota, USA
  • Company Type: Publicly Traded
  • Stock: NYSE: UNH
  • Revenue: $447.6 billion (FY2025)
  • Employees: Approximately 440,000

Visit UnitedHealth Group website

View full company profile for UnitedHealth Group

Where Is Optum Rx Made / Based?

  • Headquarters: Minnetonka, Minnesota, USA
  • Manufacturing / Operations: United States

Optum Rx Sustainability & Ethics

OptumRx's sustainability and ethical framework operates within UnitedHealth Group's corporate responsibility programs. As one of the three largest pharmacy benefits managers in the United States, OptumRx's initiatives focus on responsible pharmaceutical services, community pharmacy support, and ethical business practices.

Community Pharmacy Support: In 2025, OptumRx expanded support for independent pharmacies through increased reimbursement for brand drugs. The company increased brand drug reimbursement for approximately 2,300 independent pharmacies, contributing to healthcare access in local communities.

Ethical Pharmacy Benefits Management: In 2025, UnitedHealth Group committed to passing through 100% of drug rebates received from pharmaceutical manufacturers to plan sponsors. This policy change represented a significant shift toward more transparent pricing practices, responding to increasing regulatory and political pressure on PBM rebate practices.

Digital Health and Efficiency: OptumRx's digitally enabled pharmacy services leverage technology to improve service delivery. The company uses technology to help care teams close gaps in care, improving efficiency and reducing the need for physical infrastructure.

Environmental Initiatives: UnitedHealth Group has established environmental sustainability initiatives addressing the health impacts of climate change. OptumRx supports these initiatives through sustainable pharmacy operations and reduced environmental footprint.

Awards & Recognition

OptumRx is recognized as one of the three largest pharmacy benefits managers in the United States, alongside CVS Caremark and Express Scripts. The company processed 1.66 billion adjusted scripts in fiscal year 2025 and generated $154.7 billion in revenues, demonstrating market leadership in the PBM sector.

OptumRx's expanded support for independent pharmacies has been acknowledged as an important initiative for supporting local healthcare infrastructure. The company's commitment to increased reimbursement for 2,300 independent pharmacies has been recognized as contributing to healthcare access in local communities.

OptumRx's innovative approaches to pharmacy benefits management, including the Clear Trend Guarantee and Cost Made Clear payment solutions, have been acknowledged for improving cost transparency for plan sponsors.

OptumRx's strong financial performance in 2025, including 16% revenue growth to $154.7 billion and earnings from operations of $7.2 billion, has been acknowledged as evidence of successful business strategy and market execution.

Optum Rx Recalls & Controversies

OptumRx has faced regulatory scrutiny and legal challenges, primarily related to business practices, rebate transparency, and market dominance concerns.

Department of Justice Investigation (2024): OptumRx faced investigation by the Department of Justice regarding business practices, including the prescription management services of OptumRx. This investigation was part of broader scrutiny of UnitedHealth Group's business practices and market dominance in healthcare services.

FTC Action and Response (2024): OptumRx responded to FTC action regarding pharmacy benefits management practices. This regulatory scrutiny reflected increasing attention on pharmacy benefits managers' business practices and market power.

Kentucky Counties Lawsuits: OptumRx invoked the Open Meetings Law to fight Kentucky counties on opioid-related lawsuits, representing a controversial legal strategy. Oldham County's annual budget was less than 0.1% of OptumRx's annual revenue.

Rebate Practice Controversy: OptumRx's traditional practice of retaining drug rebates rather than passing them through to plan sponsors has faced criticism and regulatory pressure. The company's 2025 commitment to passing through 100% of drug rebates represented a significant policy change in response to these concerns.

Market Dominance Concerns: OptumRx's position as one of the three largest PBMs, along with CVS Caremark and Express Scripts, has raised concerns about market concentration and potential anti-competitive practices. The company's market power in pharmacy benefits management has been scrutinized by regulators and policymakers.

Leadership Transition: In May 2025, CEO Andrew Witty stepped down and Stephen Hemsley returned as CEO. The transition occurred amid government investigations, higher than expected medical costs, and public scrutiny following the December 2024 murder of UnitedHealthcare CEO Brian Thompson. UnitedHealth Group also withdrew its 2025 financial outlook at the time of the leadership change.

Brands Owned by UnitedHealth Group

Change HealthcareHealthcare Pharmaceuticals

Change Healthcare

Owned by UnitedHealth Group

Healthcare technology company providing claims processing and payment solutions, owned by UnitedHealth Group.

healthcare-technologyclaims-processingpayment-solutions
Optum BankFinance Fintech

Optum Bank

Owned by UnitedHealth Group

UnitedHealth Group's FDIC-insured bank subsidiary and the largest health savings account (HSA) administrator in the United States, managing more than $21 billion in HSA assets for millions of account holders.

health-savings-accounthsafsa
Optum HealthHealthcare Pharmaceuticals

Optum Health

Owned by UnitedHealth Group

UnitedHealth Group's healthcare delivery and value-based care division employing or affiliating with more than 90,000 physicians, generating $105.4 billion in 2024 revenue as one of the largest physician employers in the United States.

primary-carevalue-based-carephysician-employment
Optum InsightHealthcare Pharmaceuticals

Optum Insight

Owned by UnitedHealth Group

UnitedHealth Group's healthcare data analytics and technology division, which acquired Change Healthcare for $13 billion in 2022 and generated $19.4 billion in 2025 revenue. The division completed its acquisition of Alegeus in July 2026 and continues to develop AI-enabled healthcare products including autonomous coding and digital prior authorization tools.

data-analyticschange-healthcarehealth-technology
OptumHealthcare Pharmaceuticals

Optum

Owned by UnitedHealth Group

UnitedHealth Group's healthcare services platform formed in 2011, operating through Optum Health, Optum Insight, and Optum Rx to generate $270.6 billion in combined 2025 revenues and supporting more than 123 million consumers.

healthcare-serviceshealth-technologypharmacy-benefits
UnitedHealthcareHealthcare Pharmaceuticals

UnitedHealthcare

Owned by UnitedHealth Group

UnitedHealth Group's health insurance brand providing coverage for individuals, employers, Medicare, and Medicaid recipients.

health-insurancemedical-coveragehealthcare
View all brands owned by UnitedHealth Group

Optum Rx Ownership: Pros & Cons

Advantages

  • +OptumRx's 1.66 billion adjusted scripts processed in 2025 give the business significant purchasing leverage with pharmaceutical manufacturers, enabling competitive drug pricing for plan sponsors and members
  • +UnitedHealthcare's 49.8 million consumers in 2025 provide OptumRx with a large captive customer base that generates predictable revenue without requiring competitive bidding for each contract
  • +The 2015 Catamaran acquisition, for approximately $12.8 billion, transformed OptumRx from a mid-tier pharmacy benefits manager into one of the three largest PBMs in the United States, providing scale advantages in drug purchasing, technology, and client service
  • +OptumRx's integration with UnitedHealthcare's insurance operations and Optum Health's care delivery capabilities enables data-driven medication management that can improve adherence and health outcomes for members
  • +UnitedHealth Group's $447.6 billion in 2025 revenues provides OptumRx with investment capacity for technology development, specialty pharmacy expansion, and client service capabilities that smaller pharmacy benefits managers cannot match

Considerations

  • -OptumRx's 2025 commitment to pass through 100% of drug rebates to plan sponsors represents a significant business model change that could reduce revenue and profitability if not offset by other fee arrangements
  • -The pharmacy benefits management market faces increasing regulatory and political scrutiny, with the FTC's 2024 report critical of large PBM practices and proposed congressional legislation targeting PBM reform
  • -OptumRx's vertical integration with UnitedHealthcare's insurance operations creates potential conflicts of interest, as the combined entity has financial incentives to direct members toward OptumRx's mail-order and specialty pharmacy services even when retail alternatives might be more convenient
  • -Competition from CVS Caremark and Express Scripts, both of which have larger pharmacy retail networks and longer operating histories in the PBM market, creates sustained competitive pressure for external client acquisition
  • -The 2026 outlook projects a revenue decline to approximately $150.5 billion due to membership attrition in UnitedHealthcare, reflecting the business's dependence on the parent company's insurance membership levels

Frequently Asked Questions About Optum Rx

Sources & Further Reading

  • [UnitedHealth Group 2025 Annual Results]( -- January 27, 2026
  • [SEC EDGAR: UnitedHealth Group (UNH) 10-K Filing]( -- Fiscal Year 2025
  • [UnitedHealth Group Investor Relations](
  • [UnitedHealth Group Leadership Transition Announcement]( -- May 13, 2025
  • [OptumRx Official Website](
  • [UnitedHealth Group Corporate Website](
  • [Federal Trade Commission PBM Report](
  • [Department of Justice](
  • [KFF Health News](
  • [Fierce Healthcare PBM Coverage](

Where to Buy

Disclosure: We may earn commission from purchases
AmazonOptum Rx on Amazon

Competitors to Optum Rx

These competing brands operate in the same categories and provide similar products or services. Compare key attributes to understand market positioning and competitive landscape.

BrandParent CompanyCountryFoundedMarket PositionPrimary MarketGender Target
Express ScriptsExpress Scripts
Cigna
USA
1986
Mass marketUnited statesAll-ages
CaremarkCaremark
Cvs Health
USA
1993
Mass marketUnited StatesAll Genders

Learn More About Competitors

Express ScriptsHealthcare Pharmaceuticals

Express Scripts

Owned by The Cigna Group

One of the largest pharmacy benefit managers in the United States, owned by The Cigna Group and operating within its Evernorth Health Services division.

pharmacy-benefitsmail-order-pharmacyprescription-drugs
CaremarkHealthcare Pharmaceuticals

Caremark

Owned by CVS Health

Pharmacy benefit manager owned by CVS Health, administering prescription drug benefits for employers and health plans. In July 2026, Caremark reached a settlement with the FTC over insulin pricing and rebate practices.

pharmacy-benefit-managerpbmprescription-drugs

Competitive Analysis

Market Positioning: Optum Rx competes with 2 brands in the same categories, ranging from mass market to luxury positioning.

Geographic Distribution: Competitors are headquartered across multiple regions, indicating global competition in this market segment.

Brand Heritage: Competitor brands range from established heritage brands to newer market entrants, with founding years spanning several decades.

Independent Alternatives to Optum Rx

Looking for brands with different ownership structures? These similar brands are not owned by UnitedHealth Group, giving you alternative choices that support different corporate structures.

One MedicalHealthcare Pharmaceuticals

One Medical

Owned by Unknown Company

Amazon-owned membership-based primary care practice operating nearly 240 offices across more than 20 U.S. markets with 24/7 virtual care.

healthcareprimary-caretelemedicine
Independent

One Medical operates independently without a large parent corporation.

PfizerHealthcare Pharmaceuticals

Pfizer

Owned by Pfizer

American multinational pharmaceutical corporation developing and manufacturing medicines, vaccines, and consumer healthcare products, one of the world's largest pharmaceutical companies.

pharmaceuticalvaccinesmedicines
Publicly Traded

Pfizer operates independently without a large parent corporation.

GE HealthCareHealthcare Pharmaceuticals

GE HealthCare

Owned by GE HealthCare Technologies Inc.

Independent publicly traded healthcare technology company spun off from General Electric in January 2023, providing medical imaging, diagnostics, and healthcare IT solutions globally.

healthcare-technologymedical-imagingdiagnostics
Publicly Traded

GE HealthCare operates independently without a large parent corporation.

Leica MicrosystemsHealthcare Pharmaceuticals

Leica Microsystems

Owned by Unknown Company

Leading manufacturer of microscopes and scientific instrumentation for the analysis of microstructures and nanostructures, headquartered in Wetzlar, Germany. A wholly-owned subsidiary of Danaher Corporation, with products including AI-powered imaging software, fluorescence microscopes, and surgical microscopes.

microscopyscientific-instrumentslife-sciences
Independent

Leica Microsystems operates independently without a large parent corporation.

PhilipsHealthcare Pharmaceuticals

Philips

Owned by Koninklijke Philips N.V.

Health technology brand owned by Koninklijke Philips N.V., a publicly traded Dutch company listed on Euronext Amsterdam (PHIA). Covers medical imaging, patient monitoring, and personal health products.

healthcare-technologyelectronicsmedical-devices
Publicly Traded

Philips operates independently without a large parent corporation.

TirosintHealthcare Pharmaceuticals

Tirosint

Owned by IBSA Institut Biochimique S.A.

IBSA Institut Biochimique SA's branded levothyroxine softgel capsule (Tirosint) and liquid solution (Tirosint-SOL), FDA approved for hypothyroidism, formulated without dyes, gluten, lactose, alcohol, or sugar, providing an excipient-free alternative to conventional levothyroxine tablets for patients with sensitivities or absorption issues.

levothyroxinehypothyroidismthyroid
Privately Owned

Tirosint is privately owned, unlike Optum Rx which is under a publicly traded parent company.

UnitedHealth Group Stock Information

Jobs at UnitedHealth Group

Latest News About Optum Rx

Related Articles About Optum Rx

View more articles
Pfizer vs Johnson & Johnson: Pharma Brand Portfolios Compared
brand comparisons

Pfizer vs Johnson & Johnson: Pharma Brand Portfolios Compared

Pfizer and Johnson & Johnson are two of the most recognizable names in healthcare. But their brand portfolios look nothing alike. Here is a complete breakdown of what each company owns, how they got there, and what sets them apart.

Who Brands StaffMar 16, 2026
pharmaceuticalpfizerjohnson and johnson
15 Pharmacy Brands and Their Corporate Parents
brand ownership

15 Pharmacy Brands and Their Corporate Parents

CVS spent $69 billion to buy Aetna. Walgreens acquired Boots for $15 billion. Amazon paid $1 billion for PillPack. Here are 15 pharmacy brands, who owns them, and how a once-diverse industry collapsed into two dominant players.

Who Brands StaffFeb 26, 2026
pharmacy brandsbrand ownershipcvs
Who Owns Your Vitamins? The Hidden Corporate Parents Behind Supplement Brands
brand ownership

Who Owns Your Vitamins? The Hidden Corporate Parents Behind Supplement Brands

The supplement industry is worth $60+ billion but most brands are owned by pharma giants and food conglomerates. Here is who owns every major vitamin and supplement brand.

Who Brands StaffFeb 5, 2026
vitaminssupplementsbrand ownership
View more articles

People Also Searched

Discover popular brands and companies in the Healthcare & Pharmaceuticals category and related searches from other users.

Accutane
Branddermatology

Accutane

Prescription isotretinoin brand developed by Roche and approved by the FDA in 1982 for severe nodular acne. Roche discontinued the brand name in the United States in 2009; the drug continues as Roaccutane in international markets.

Brand in Healthcare & Pharmaceuticals
acne-treatmentprescription
Activase
Brandpharmaceutical

Activase

Activase (alteplase) is a prescription thrombolytic medication manufactured by Genentech, a wholly-owned subsidiary of Roche. Used to treat acute ischemic stroke, heart attack, and pulmonary embolism.

Brand in Healthcare & Pharmaceuticals
thrombolyticstroke-treatment
Acuvue
Brandcontact-lenses

Acuvue

Acuvue is the world's leading contact lens brand, owned by Johnson & Johnson Vision Care, a division of Johnson & Johnson. The brand covers daily, weekly, and monthly disposable soft contact lenses sold in more than 100 countries.

Brand in Healthcare & Pharmaceuticals
vision-carejohnson-and-johnson
Browse All Healthcare & Pharmaceuticals

Last updated: August 1, 2026

On This Page

  • Who Owns It?
  • History
  • Parent Company
  • Location
  • Sustainability
  • Awards
  • Recalls
  • Related Brands
  • Pros & Cons
  • FAQ
  • Sources